Integra LifeSciences (IART) Tops Q3 EPS by 3c, Updates FY Guidance
Integra LifeSciences (NASDAQ: IART) reported Q3 EPS of $0.68, $0.03 better than the analyst ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
